Company: VRCA
Filing Date: 2025-04-11
Form Type: PRE 14A
Source: 0001193125-25-079118
Chunk: 27

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-04-11
Form: PRE 14A
Chunk 27
---
. |

| (2) | Tax fees for the fiscal years ended December 31, 2024 and 2023 include fees in connection with federal and state tax compliance, analysis of R&D tax credits and sales tax compliance. |

There were no audit-related, tax or other fees for the years ended December 31, 2024 and 2023. Pre-ApprovalPolicies and Procedures The Audit Committee has adopted a policy and procedures for the pre-approvalof audit and non-auditservices rendered by the Company’s independent auditors, KPMG LLP. The Audit Committee generally pre-approvesspecified services in the defined categories of audit services, audit-related services and tax services up to specified amounts. Pre-approvalmay also be given as part of the Audit Committee’s approval of the scope of the engagement of the independent auditor or on an individual, explicit, case-by-casebasis before the independent auditor is engaged to provide each service. The pre-approvalof services may be delegated to one or more of the Audit Committee’s members, but the decision must be reported to the full Audit Committee at its next scheduled meeting. 19

All of the services of KPMG LLP for the years ended December 31, 2024 and 2023 described above were pre-approved in accordance with the Audit Committee Pre-Approval Policy.

<div align='center'>**THE BOARD OF DIRECTORS RECOMMENDS

A VOTE “FOR” PROPOSAL NO. 3.

20

PROPOSAL NO. 4 – APPROVAL OF A SERIES OF ALTERNATE AMENDMENTS TO OUR AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO EFFECT A REVERSE STOCK SPLIT OF OUR COMMON STOCK IN THE RANGE OF 1-FOR-10 TO 1-FOR-30, INCLUSIVE**</div>

**Background

The Board has unanimously approved a series of alternate amendments to our Amended and Restated Certificate of Incorporation that would effect a Reverse Stock Split of all issued and outstanding shares of our common stock, at a ratio ranging from 1-for-10 to 1-for-30, inclusive. The text of the proposed form of amendment to our Amended and Restated Certificate of Incorporation, which we refer to as the Certificate of Amendment, is attached hereto as Appendix A.

Accordingly, effecting a Reverse Stock Split would reduce the number of outstanding shares of our common stock. The effectiveness of any one of these amendments and the abandonment of the other amendments,